President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by ...

President Donald Trump’s pick to be the next U.S. surgeon general has repeatedly said the nation’s medical, health and food ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations.

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and ...

A new partnership between Hartford HealthCare and Pfizer is taking aim at migraines in the workplace. The innovative program ...

Final Written Decisions in Pfizer’s IPR2021-00925 and IPR2021-00926 finding all challenged claims of uniQure’s U.S. Patent No. 9,982,248 (“the ’248 patent”) unpatentable (CAFC 23-1404 and 23-1405), ...

A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.